Literature DB >> 10231843

Human PACAP response gene 1 (p22/PRG1): proliferation-associated expression in pancreatic carcinoma cells.

H Schäfer1, P Lettau, A Trauzold, M Banasch, W E Schmidt.   

Abstract

p22/PACAP response gene-1 (PRG1) is a novel rat early response gene expressed during induction of proliferation and stress response. In humans, a homolog of p22/PRG1, designated IEX-1/DIF-2, exists, yet the exact function of this gene remains elusive. To characterize the expression of p22/PRG1 in human cancers, we analyzed the expression of p22/PRG1 in the human pancreatic carcinoma cell lines 818-4, PT45, and PancTu1. Serum or growth factors, like epidermal growth factor (EGF) and hepatocyte growth factor (HGF), rapidly and transiently induced transcription of p22/PRG1 in these cells, correlating with the mitogenic response. Treatment with TNF-alpha was followed by a rapid increase of p22/PRG1 messenger RNA (mRNA) levels in PT45 and Panc-Tul cells, which proliferate in the presence of TNF-alpha, but not in 818-4 cells, which are growth-inhibited when treated with TNF-alpha. Our findings suggest that human p22/PRG1 is expressed in various pancreatic carcinoma cells as a growth-associated early response gene.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10231843     DOI: 10.1097/00006676-199905000-00008

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  10 in total

1.  Divergent regulation of the growth-promoting gene IEX-1 by the p53 tumor suppressor and Sp1.

Authors:  Hee-Jeong Im; Mark R Pittelkow; Rajiv Kumar
Journal:  J Biol Chem       Date:  2002-02-13       Impact factor: 5.157

2.  Impaired apoptosis, extended duration of immune responses, and a lupus-like autoimmune disease in IEX-1-transgenic mice.

Authors:  Y Zhang; S F Schlossman; R A Edwards; Ching-Nan Ou; J Gu; Mei X Wu
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-08       Impact factor: 11.205

3.  Resistance of Sézary cells to TNF-α-induced apoptosis is mediated in part by a loss of TNFR1 and a high level of the IER3 expression.

Authors:  Oleg E Akilov; Mei X Wu; Irina V Ustyugova; Louis D Falo; Larisa J Geskin
Journal:  Exp Dermatol       Date:  2012-04       Impact factor: 3.960

4.  Immediate early gene X-1 interacts with proteins that modulate apoptosis.

Authors:  Rajiv Kumar; Ward Lutz; Elena Frank; Hee-Jeong Im
Journal:  Biochem Biophys Res Commun       Date:  2004-10-29       Impact factor: 3.575

Review 5.  Immediate early response gene X-1, a potential prognostic biomarker in cancers.

Authors:  Mei X Wu; Irina V Ustyugova; Liping Han; Oleg E Akilov
Journal:  Expert Opin Ther Targets       Date:  2013-02-04       Impact factor: 6.902

Review 6.  A novel vitamin D-regulated immediate-early gene, IEX-1, alters cellular growth and apoptosis.

Authors:  Rajiv Kumar; Mark R Pittelkow; Jeffrey L Salisbury; Joseph P Grande; Hee-Jeong Im; Kathrin A Feldmann; David Schilling
Journal:  Recent Results Cancer Res       Date:  2003

7.  The stress-inducible immediate-early responsive gene IEX-1 is activated in cells infected with herpes simplex virus 1, but several viral mechanisms, including 3' degradation of its RNA, preclude expression of the gene.

Authors:  Brunella Taddeo; Audrey Esclatine; Weiran Zhang; Bernard Roizman
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

8.  Dysregulated IER3 Expression is Associated with Enhanced Apoptosis in Titin-Based Dilated Cardiomyopathy.

Authors:  Qifeng Zhou; Julia Kelley Hahn; Balram Neupane; Parwez Aidery; Siegfried Labeit; Meinrad Gawaz; Michael Gramlich
Journal:  Int J Mol Sci       Date:  2017-03-29       Impact factor: 5.923

9.  IF-combined smRNA FISH reveals interaction of MCPIP1 protein with IER3 mRNA.

Authors:  Jakub Kochan; Mateusz Wawro; Aneta Kasza
Journal:  Biol Open       Date:  2016-07-15       Impact factor: 2.422

10.  PACAP and PAC1 receptor expression in pancreatic ductal carcinoma.

Authors:  Sandor Ferencz; Dora Reglodi; Balint Kaszas; Attila Bardosi; Denes Toth; Zsofia Vekony; Viktoria Vicena; Oszkar Karadi; Dezso Kelemen
Journal:  Oncol Lett       Date:  2019-10-08       Impact factor: 2.967

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.